RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $119,000 | -26.5% | 10,309 | -36.3% | 0.00% | – |
| Q4 2021 | $162,000 | -34.1% | 16,190 | -14.1% | 0.00% | – |
| Q3 2021 | $246,000 | -50.2% | 18,850 | -25.4% | 0.00% | – |
| Q2 2021 | $494,000 | -45.4% | 25,255 | -40.7% | 0.00% | -100.0% |
| Q1 2021 | $905,000 | -10.1% | 42,555 | +25.6% | 0.00% | 0.0% |
| Q4 2020 | $1,007,000 | +0.1% | 33,876 | -27.0% | 0.00% | 0.0% |
| Q3 2020 | $1,006,000 | +28.2% | 46,427 | +32.0% | 0.00% | 0.0% |
| Q2 2020 | $785,000 | +70.3% | 35,185 | +16.3% | 0.00% | – |
| Q1 2020 | $461,000 | -26.7% | 30,262 | +3.9% | 0.00% | -100.0% |
| Q3 2019 | $629,000 | -2.2% | 29,117 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $643,000 | +0.2% | 29,217 | +24.7% | 0.00% | 0.0% |
| Q1 2019 | $642,000 | -18.2% | 23,429 | -19.8% | 0.00% | 0.0% |
| Q4 2018 | $785,000 | -20.7% | 29,199 | -14.0% | 0.00% | 0.0% |
| Q3 2018 | $990,000 | +14.2% | 33,945 | +22.4% | 0.00% | 0.0% |
| Q2 2018 | $867,000 | +110.4% | 27,727 | +33.8% | 0.00% | – |
| Q1 2018 | $412,000 | -31.4% | 20,717 | +0.2% | 0.00% | -100.0% |
| Q4 2017 | $601,000 | – | 20,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |